The precise mechanism by which hormone-induced cAMP levels act at mitochondria to activate cholesterol transport and steroid synthesis is unknown. We propose that this mechanism involves a macromolecular signaling complex where a newly identified peripheral-type benzodiazepine receptor (PBR)-associated protein (PAP7) binds the regulatory subunit RI-alpha of the cAMP-dependent protein kinase (PKA), thus allowing for local (mitochondrial) efficient catalytic activation and phosphorylation of the substrate steroidogenesis acute regulatory protein (StAR), leading to cholesterol transfer through the high affinity cholesterol binding protein PBR into the inner mitochondrial membrane. The mouse and human PAP7 proteins were cloned, their genomic organization, tissue distribution and subcellular localization in Leydig cells characterized. PAP7 is highly expressed in steroidogenic tissues, where it follows the pattern of PKA-RI-alpha expression and data from a human adrenal disease suggest that it participates in PKA-RI-alpha-mediated tumorigenesis and hormone-independent hypercortisolism. PAP7 is localized in the Golgi and mitochondria and inhibition of PAP7 expression results in reduced hormone-induced cholesterol transport into mitochondria and decreased steroid formation. Taken together these data suggest that PAP7 functions as an A-kinase anchoring protein (AKAP), a """"""""scaffold"""""""" protein that targets cAMP signaling to mitochondria where steroidogenesis begins. These studies will be extended with four specific aims. In the first aim we will establish the temporal and spatial relationship of the components present in this mitochondrial cAMP transduceosome and the effects of hormone treatment. In the second aim, we will examine the molecular determinants defining the binding and specificity of the interaction among the various components of the complex. In the third aim, we will investigate whether the PKA-RI-alphaPAP7/PBR assembly facilitates StAR phosphorylation and cholesterol transport into mitochondria. In the fourth aim, we will determine the in vivo function of the """"""""molecular switch"""""""" PAP7 by gene targeting at the animal and steroidogenic cell levels. Data generated from these studies should test our hypothesis that a mitochondrial cAMP signaling complex (transduceosome) directs and amplifies the effects of cAMP leading to the induction and maintenance of steroidogenesis.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD037031-06A1
Application #
6820359
Study Section
Reproductive Biology Study Section (REB)
Program Officer
Rankin, Tracy L
Project Start
1998-12-15
Project End
2009-06-30
Budget Start
2004-07-15
Budget End
2005-06-30
Support Year
6
Fiscal Year
2004
Total Cost
$314,280
Indirect Cost
Name
Georgetown University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lecanu, Laurent; Yao, Zhi-Xing; McCourty, Althea et al. (2013) Control of hypercholesterolemia and atherosclerosis using the cholesterol recognition/interaction amino acid sequence of the translocator protein TSPO. Steroids 78:137-46
Midzak, Andrew; Akula, Nagaraju; Lecanu, Laurent et al. (2011) Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J Biol Chem 286:9875-87
Fan, Jinjiang; Liu, Jun; Culty, Martine et al. (2010) Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog Lipid Res 49:218-34
Fan, Jinjiang; Rone, Malena B; Papadopoulos, Vassilios (2009) Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis. J Biol Chem 284:30484-97
Rone, Malena B; Liu, Jun; Blonder, Josip et al. (2009) Targeting and insertion of the cholesterol-binding translocator protein into the outer mitochondrial membrane. Biochemistry 48:6909-20
Papadopoulos, Vassilios; Lecanu, Laurent (2009) Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp Neurol 219:53-7
Rone, Malena B; Fan, Jinjiang; Papadopoulos, Vassilios (2009) Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states. Biochim Biophys Acta 1791:646-58
Ostuni, Mariano Anibal; PĂ©ranzi, Gabriel; Ducroc, Robert A et al. (2009) Distribution, pharmacological characterization and function of the 18 kDa translocator protein in rat small intestine. Biol Cell 101:573-86
Ostuni, Mariano A; Ducroc, Robert; Peranzi, Gabriel et al. (2007) Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells. Biol Cell 99:639-47
Veenman, Leo; Papadopoulos, Vassilios; Gavish, Moshe (2007) Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des 13:2385-405

Showing the most recent 10 out of 18 publications